4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-23-000039
CIK 0001479290other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 3:21 PM ET
Size
4.8 KB
Accession
0001479290-23-000039
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2023-03-15$30.65/sh−2,967$90,939→ 120,967 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock award (the"RSA") for 7,540 shares. The RSA vests in three equal annual installments from March 15, 2021.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 3:21 PM ET
- Size
- 4.8 KB